Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.33 |
| ▸ | MAPT | P10636 | 5/20 | 0.33 |
| ▸ | HPGD | P15428 | 4/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 4/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | CASP6 | P55212 | 1/20 | 0.30 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL153944 | 0.91 | ALDH1A1 (0.37) | ALDH1A1MAPTHPGDCYP2A6MEN1 | |
| Phosphine SCHEMBL27314409 | 0.90 | ALDH1A1 (0.36) | ALDH1A1MAPTHPGDCYP2A6MEN1 | |
| Sulfuric Acid SCHEMBL4223494 | 0.87 | CA1 (0.34) | ALDH1A1MAPTHPGDCYP2A6MEN1 | |
| Phosphoric Acid SCHEMBL27555357 | 0.87 | MEN1 (0.37) | ALDH1A1MAPTHPGDMEN1KMT2A | |
| SCHEMBL5268855 | 0.86 | ALDH1A1 (0.35) | ALDH1A1MAPTHPGDCYP2A6MEN1 | |
| Acetic Acid SCHEMBL1278526 | 0.85 | ALDH1A1 (0.36) | ALDH1A1MAPTHPGDCYP2A6MEN1 | |
| Acetic Acid SCHEMBL4229015 | 0.85 | ALDH1A1 (0.36) | ALDH1A1MAPTHPGDCYP2A6MEN1 | |
| Phosphoric Acid SCHEMBL29008762 | 0.82 | CYP2A6 (0.32) | CYP2A6 | |
| Phosphoric Acid SCHEMBL29206149 | 0.82 | CYP2A6 (0.32) | CYP2A6 | |
| SCHEMBL27328670 | 0.80 | CYP2A6 (0.33) | CYP2A6P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 415 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630857-B2 | Biological indicator for determining the efficacy of a steam or heat sterilization process and its method of use | TERRAGENE LLC (US) | 2026-05-19 | — | — | US | claimed |
| EP-4363602-B1 | BIOLOGICAL INDICATOR FOR DETERMINING THE EFFICACY OF AN OXIDATIVE STERILIZATION PROCESS AND METHODS OF USE | TERRAGENE LLC (US) | 2025-11-26 | — | — | EP | claimed |
| US-12448642-B2 | Biological indicator for determining the efficacy of an oxidative sterilization process and methods of use | TERRAGENE LLC (US) | 2025-10-21 | — | — | US | claimed |
| US-20250084452-A1 | BIOLOGICAL INDICATOR FOR DETERMINING THE EFFICACY OF A STERILIZATION PROCESS AND METHODS OF USE | TERRAGENE LLC | 2025-03-13 | — | — | US | claimed |
| EP-4363602-A1 | BIOLOGICAL INDICATOR FOR DETERMINING THE EFFICACY OF AN OXIDATIVE STERILIZATION PROCESS AND METHODS OF USE | Terragene LLC (US) | 2024-05-08 | — | — | EP | claimed |
| US-20240110219-A1 | BIOLOGICAL INDICATOR FOR DETERMINING THE EFFICACY OF A STEAM OR HEAT STERILIZATION PROCESS AND ITS METHOD OF USE | TERRAGENE LLC | 2024-04-04 | — | — | US | claimed |
| CN-117693594-A | Biological indicators for determining efficacy of oxidative sterilization processes and methods of use | 特拉吉恩有限责任公司 | 2024-03-12 | — | — | CN | claimed |
| US-11884960-B2 | Biological indicator for determining the efficacy of a steam or heat sterilization process and its method of use | TERRAGENE LLC (US) | 2024-01-30 | — | — | US | claimed |
| WO-2023275830-A1 | BIOLOGICAL INDICATOR FOR DETERMINING THE EFFICACY OF AN OXIDATIVE STERILIZATION PROCESS AND METHODS OF USE | TERRAGENE LLC (US) | 2023-01-05 | — | — | WO | claimed |
| US-20230002802-A1 | BIOLOGICAL INDICATOR FOR DETERMINING THE EFFICACY OF AN OXIDATIVE STERILIZATION PROCESS AND METHODS OF USE | TERRAGENE LLC | 2023-01-05 | — | — | US | claimed |
| US-5916746-A | POLYNUCLEOTIDE HYBRIDIZATION WHEREIN PRESENCE IN A SAMPLE OF A TARGET POLYNUCLEOTIDE MOLECULE IS DETERMINED BY A DETECTION SYSTEM COMPRISING A POLYNUCLEOTIDE PROBE WHICH HYBRIDIZES TO SAID TARGET AND A REPORTER MOLECULE COMPRISING AN ENZYME | KIRKEGAARD & PERRY LABORATORIES, INC. (US) | 1999-06-29 | — | — | US | claimed |
| EP-0922112-A1 | FORMAZAN-BASED IMMUNOASSAY | Kirkegaard & Perry Laboratories, Inc. (US) | 1999-06-16 | — | — | EP | claimed |
| WO-1997042342-A1 | FORMAZAN-BASED IMMUNOASSAY | KIRKEGAARD & PERRY LABORATORIES, INC. (US) | 1997-11-13 | — | — | WO | claimed |
| EP-0415983-B1 | ASSAY DEVICE AND IMMUNOASSAY | DU PONT (US) | 1995-11-22 | — | — | EP | claimed |
| US-5443958-A | 2-acrylamine-2-methyl-1-propanesulfonic acid enhancement of alkaline phosphatase label detection | DIRECTOR-GENERAL, NATIONAL INSTITUTE OF ANIMAL INDUSTRY (JP) | 1995-08-22 | — | — | US | claimed |
| US-5395754-A | Membrane-based immunoassay method | HYBRITECH INCORPORATED (US) | 1995-03-07 | — | — | US | claimed |
| US-5391478-A | Assay device and immunoassay | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-02-21 | — | — | US | claimed |
| US-5382516-A | Method and devices for delivery of substrate for the detection of enzyme-linked, membrane-based binding assays | SCHLEICHER & SCHUELL, INC. (US) | 1995-01-17 | — | — | US | claimed |
| US-5137804-A | ASSAY DEVICE AND IMMUNOASSAY | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-08-11 | — | — | US | claimed |
| US-4892817-A | INDOXYL PHOSPHATE, TETRAZOLIUM SALT, AND WATER SOLUBLE FERRICYANIDE FERROCYANIDE SALT | BIOGENEX LABORATORIES (US) | 1990-01-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630857-B2 | Biological indicator for determining the efficacy of a steam or heat sterilization process and its method of use | HSF1, SPOUT1, HSPA2 | ALDH1A1 498/4885MAPT 3125/4885HPGD 3109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.